HROW Live signals | Maximize Profits with Getagraph.com

SELL 95207 min ago

@ $11.34

Issued: 13 Feb 2024 @ 15:41

Return: -7.85%

Previous signal: Feb 12 - 15:34

Previous signal: Buy

Return: -3.57 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	670 836
Average Volume	437 877
Market Cap	369.54M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.250 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-13.93
ATR14	$0.0210 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Opaleye Management Inc.	Buy	29 400	Common Stock, par value $0.001 per share
2024-03-28	Opaleye Management Inc.	Buy	50 000	Common Stock, par value $0.001 per share
2024-03-22	Baum Mark L	Buy	9 000	Common stock
2024-03-20	Opaleye Management Inc.	Buy	50 600	Common Stock, par value $0.001 per share
2024-03-01	Saharek John P.	Buy	5 000	Common stock

INSIDER POWER
12.15
Last 95 transactions
Buy: 4 610 889 \| Sell: 3 289 598

Volume Correlation

Long: -0.21 (neutral)

Short: 0.49 (neutral)

Signal:(44.965) Neutral

Harrow Health Inc Correlation

10 Most Positive Correlations
SY	0.94
BRIVU	0.939
ARTEU	0.939
ALSA	0.936
PPYAU	0.935
IOAC	0.935
LCAA	0.934
GPACU	0.934
ATEC	0.933
ALTR	0.933

10 Most Negative Correlations
CSSEP	-0.947
GOOD	-0.946
NAKD	-0.933
JAGX	-0.932
PCSA	-0.931
SIDU	-0.93
VFF	-0.929
NARI	-0.925
ALXO	-0.924
XPDI	-0.924

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Harrow Health Inc Correlation - Currency/Commodity

0.85
( strong )

0.83
( strong )

0.00
( neutral )

0.76
( moderate )

-0.14
( neutral )

0.30
( neutral )

Harrow Health Inc Financials

Annual	2023
Revenue:	$130.19M
Gross Profit:	$90.55M (69.55 %)
EPS:	$-0.750

Q4	2023
Revenue:	$36.36M
Gross Profit:	$25.05M (68.91 %)
EPS:	$-0.260

Q3	2023
Revenue:	$34.27M
Gross Profit:	$24.20M (70.62 %)
EPS:	$-0.130

Q2	2023
Revenue:	$33.47M
Gross Profit:	$23.47M (70.12 %)
EPS:	$-0.140

Financial Reports:

No articles found.

Harrow Health Inc

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.